Doç. Dr. BELGİN SEVER

Dr. Belgin Sever is currently an Associate Professor at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University. Her research is mainly focused on the development of anticancer, antimicrobial, antidiabetic, anti-HIV and anti-ALS drug candidates, especially based on medicinal chemistry and computational chemistry disciplines. She has published many high quality articles in prestigious international peer-reviewed journals indexed by Science Citation Index (SCI) and SCI-Expanded. She was awarded first rank in her graduation from Anadolu University, Faculty of Pharmacy in 2013. She received her MSc and PhD in Pharmaceutical Chemistry from Anadolu University, Faculty of Pharmacy in 2015 and 2019, respectively. During her PhD studies, she was a recipient of the 2211-A National Scholarship Programme of the Scientific and Technological Research Council of Turkey (TUBITAK). After her PhD, she was accepted as a postdoctoral researcher of the Takeda Science Foundation International Fellowship Programme. During this time, she worked on anti-HIV drug development at Kumamoto University, Faculty of Life Sciences, Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Kumamoto, Japan from November 2020 to May 2021. Then, she was also accepted for TUBITAK 2219-International Postdoctoral Research Fellowship Programme to conduct anticancer research at the same laboratory, Faculty of Life Sciences, Kumamoto University from June 2022 to June 2023. She continues her research on anti-ALS drug development as a Japan Society for the Promotion of Science (JSPS) Postdoctoral Researcher in Japan at the same research laboratory, Faculty of Life Sciences, Kumamoto University. She was selected as "Young Woman Researcher" in the 7th Women Awards - Venus International Women Awards (VIWA) 2022" based on the VIWA 2022 Expert Committee Report and Apex Committee Recommendations. She was also awarded by the Turkish Pharmacists' Association - Academy of Pharmacy in 2022 for her contributions to pharmaceutical science. She has served on the editorial boards of Open Chemistry, Plos One, Heliyon-Pharmaceutical Science, Current Topics in Medicinal Chemistry, Frontiers in Chemistry, Frontiers in Chemical Biology, Oncology Research, Discover Oncology and Scientific Reports. She has also served as a topic editor for Pharmaceuticals, Molecules and Life.